The chair of Winston & Strawn’s litigation practice is reportedly set to jump to Kirkland & Eliis and join its executive committee.
James Hurst, who specializes in litigation and intellectual property, has several antitrust cases under his belt – most notably, he secured a win in 2011 in defending Abbott Laboratories accused of fixing drug prices.
According to reports, while not unprecedented, it is unusual for law firms to make a lateral hire of the executive team. Kirkland says Hurst will focus on representing pharmaceutical companies that make branded drugs; Winston, on the other hand, represents several generic drug makers, so Hurt’s move will not pose a conflict of interest, reports say.
Full content: Chicago Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI